HemoPred: a web server for predicting the hemolytic activity of peptides

Papers of special note have been highlighted as: •• of considerable interest

References

• 1 Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Synthetic therapeutic peptides: science and market. Drug Discov. Today 15(1–2), 40–56 (2010).
  Medline CASGoogle Scholar
• 2 Gutte B. Peptides-synthesis, structures and applications. Biochem. Educ. 24(4), 551 (1996).
  Google Scholar
• 3 Mor A. Peptides: biological activities of small peptides. eLS: Encyclopedia of Life Sciences. John Wiley & Sons, Inc., NJ, USA (2001).
  Google Scholar
• 4 Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24(12), 1551–1557 (2006).
  Medline CASGoogle Scholar
• 5 Otvos L Jr, Wade JD. Current challenges in peptide-based drug discovery. Front. Chem. 2, 62 (2014).
  MedlineGoogle Scholar
• 6 Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem. Biol. Drug Des. 81(1), 136–147 (2013).
  Medline CASGoogle Scholar
• 7 Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov. Today 20(1), 122–128 (2015).
  Medline CASGoogle Scholar
• 8 Antosova Z, Mackova M, Kral V, Macek T. Therapeutic application of peptides and proteins: parenteral forever? Trends Biotechnol. 27(11), 628–635 (2009).
  Medline CASGoogle Scholar
• 9 Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm. Res. 27(4), 544–575 (2010).
  MedlineGoogle Scholar
• 10 Pichereau C, Allary C. Therapeutic peptides under the spotlight. (2005). http://bionest.com/wp-content/uploads/2015/10/TherapeuticPeptides.pdf.
  Google Scholar
• 11 Eddershaw PJ, Beresford AP, Bayliss MK. ADME/PK as part of a rational approach to drug discovery. Drug Discov. Today 5(9), 409–414 (2000).
  Medline CASGoogle Scholar
• 12 Gautam A, Chaudhary K, Singh S et al. Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res. 42, D444–D449 (2014). •• A manually curated database of hemolytic and nonhemolytic peptides has been reported for the first time.
  Medline CASGoogle Scholar
• 13 van de Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. 2(3), 192–204 (2003).
  Medline CASGoogle Scholar
• 14 Uchide N, Ohyama K, Bessho T, Toyoda H. Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells. Intervirology 52(3), 164–173 (2009).
  Medline CASGoogle Scholar
• 15 Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 160(2), 171–177 (2006).
  Medline CASGoogle Scholar
• 16 Cree IA, Andreotti PE. Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines. Toxicol. In Vitro 11, 553–556 (1997).
  Medline CASGoogle Scholar
• 17 Evans BC, Nelson CE, Yu SS et al. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J. Vis. Exp. (73), e50166 (2013).
  MedlineGoogle Scholar
• 18 Zhou P, Huang J. Computational Peptidology. Humana Press, NY, USA (2015).
  Google Scholar
• 19 Diez-Silva M, Dao M, Han J, Lim CT, Suresh S. Shape and biomechanical characteristics of human red blood cells in health and disease. MRS Bull. 35(5), 382–388 (2010).
  Medline CASGoogle Scholar
• 20 Jeswani G, Alexander A, Saraf S, Saraf S, Qureshi A, Ajazuddin. Recent approaches for reducing hemolytic activity of chemotherapeutic agents. J. Control. Release 211, 10–21 (2015).
  Medline CASGoogle Scholar
• 21 Schmaier AH, Lazarus HM. Concise Guide To Hematology. Wiley-Blackwell, NJ, USA, 352 (2012).
  Google Scholar
• 22 Wahed A, Dasgupta A. Hematology and Coagulation. Elsevier, Amsterdam, Netherlands (2015).
  Google Scholar
• 23 Foerster J, Greer JP, Wintrobe MM. Wintrobe's Clinical Hematology. Lippincott Williams & Wilkins, PA, USA (2014).
  Google Scholar
• 24 Gladwin MT, Kanias T, Kim-Shapiro DB. Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J. Clin. Invest. 122(4), 1205–1208 (2012).
  Medline CASGoogle Scholar
• 25 Bryan NS, Bian K, Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front. Biosci. 14, 1–18 (2008).
  Google Scholar
• 26 Kawashima S, Kanehisa M. AA index: amino acid index database. Nucleic Acids Res. 28(1), 374 (2000).
  Medline CASGoogle Scholar
• 27 HemoPred: a web server for predicting the hemolytic activity of peptides. http://codes.bio/hemopred/.
  Google Scholar
• 28 Chaudhary K, Kumar R, Singh S et al. A web server and mobile app for computing hemolytic potency of peptides. Sci. Rep. 6, 22843 (2016). •• The HemoPI web server for predicting the hemolytic potency of peptides is used to benchmark with the findings reported herein.
  Medline CASGoogle Scholar
• 29 Gogoladze G, Grigolava M, Vishnepolsky B et al. DBAASP: database of antimicrobial activity and structure of peptides. FEMS Microbiol. Lett. 357(1), 63–68 (2014).
  Medline CASGoogle Scholar
• 30 Shoombuatong W, Mekha P, Waiyamai K, Cheevadhanarak S, Chaijaruwanicha J. Prediction of human leukocyte antigen gene using k-nearest neighbour classifier based on spectrum kernel. ScienceAsia 39(1), 42–49 (2013).
  CASGoogle Scholar
• 31 Shoombuatong W, Mekha P, Chaijaruwanich J. Sequence based human leukocyte antigen gene prediction using informative physicochemical properties. Int. J. Data Min. Bioinform. 13(3), 211–224 (2015).
  MedlineGoogle Scholar
• 32 Shoombuatong W, Huang HL, Chaijaruwanich J, Charoenkwan P, Lee HC, Ho SY. Predicting protein crystallization using a simple scoring card method. Presented at: 2013 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB). Singapore, 15–19 April 2013.
  Google Scholar
• 33 Charoenkwan P, Shoombuatong W, Lee HC, Chaijaruwanich J, Huang HL, Ho SY. SCMCRYS: predicting protein crystallization using an ensemble scoring card method with estimating propensity scores of P-collocated amino acid pairs. PLoS ONE 8(9), e72368 (2013).
  Medline CASGoogle Scholar
• 34 Tung CW, Ziehm M, Kämper A, Kohlbacher O, Ho SY. POPISK: T-cell reactivity prediction using support vector machines and string kernels. BMC Bioinformatics 12, 446 (2011).
  Medline CASGoogle Scholar
• 35 Liaw C, Tung C-W, Ho SY. Prediction and analysis of antibody amyloidogenesis from sequences. PLoS ONE 8(1), e53235 (2013).
  Medline CASGoogle Scholar
• 36 Gupta S, Kapoor P, Chaudhary K et al. In silico approach for predicting toxicity of peptides and proteins. PLoS ONE 8(9), e73957 (2013).
  Medline CASGoogle Scholar
• 37 Kumar R, Chaudhary K, Singh Chauhan J et al. An in silico platform for predicting, screening and designing of antihypertensive peptides. Sci. Rep. 5, 12512 (2015).
  MedlineGoogle Scholar
• 38 Tyagi A, Kapoor P, Kumar R, Chaudhary K, Gautam A, Raghava GP. In silico models for designing and discovering novel anticancer peptides. Sci. Rep. 3, 2984 (2013).
  MedlineGoogle Scholar
• 39 Shoombuatong W, Hongjaisee S, Barin F, Chaijaruwanich J, Samleerat T. HIV-1 CRF01_AE coreceptor usage prediction using kernel methods based logistic model trees. Comput. Biol. Med. 42(9), 885–889 (2012).
  Medline CASGoogle Scholar
• 40 Shoombuatong W, Prachayasittikul V, Anuwongcharoen N et al. Navigating the chemical space of dipeptidyl peptidase-4 inhibitors. Drug Des. Devel. Ther. 9, 4515–4549 (2015).
  Medline CASGoogle Scholar
• 41 Shoombuatong W, Prachayasittikul V, Prachayasittikul V, Nantasenamat C. Prediction of aromatase inhibitory activity using the efficient linear method (ELM). EXCLI J. 14, 452–464 (2015).
  MedlineGoogle Scholar
• 42 Nantasenamat C, Li H, Mandi P et al. Exploring the chemical space of aromatase inhibitors. Mol. Divers. 17(4), 661–677 (2013).
  Medline CASGoogle Scholar
• 43 Palomba D, Martinez MJ, Ponzoni I, Diaz MF, Vazquez GE, Soto AJ. QSPR models for predicting log pliver values for volatile organic compounds combining statistical methods and domain knowledge. Molecules 17(12), 14937–14953 (2012).
  Medline CASGoogle Scholar
• 44 Hammann F, Gutmann H, Baumann U, Helma C, Drewe J. Classification of cytochrome P450 activities using machine learning methods. Mol. Pharmaceut. 6(6), 1920–1926 (2009).
  Medline CASGoogle Scholar
• 45 R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2014).
  Google Scholar
• 46 Quinlan JR. C4. 5: Programs For Machine Learning. Elsevier, Amsterdam, The Netherlands (2014).
  Google Scholar
• 47 Cutler A. randomForest: Random Forests for Classification and Regression (2006). www.math.usu.edu/adele/RandomForests/UofU2013.pdf.
  Google Scholar
• 48 Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and Regression Trees. CRC Press, FL, USA (1984).
  Google Scholar
• 49 Vapnik VN, Vapnik V. Statistical Learning Theory. Wiley, NY, USA (1998).
  Google Scholar
• 50 Cortes C, Vapnik V. Support-vector networks. Mach. Learn. 20(3), 273–297 (1995).
  Google Scholar
• 51 Dimitriadou E, Hornik K, Leisch F, Meyer D, Weingessel A. e1071: misc functions of the department of statistics (e1071), TU Wien. R package version 16 (2012).
  Google Scholar
• 52 Breiman L. Random forests. Mach. Learn. 45(1), 5–32 (2001).
  Google Scholar
• 53 Calle ML, Urrea V. Letter to the editor: stability of random forest importance measures. Brief. Bioinform. 12(1), 86–89 (2011).
  MedlineGoogle Scholar
• 54 Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob. Agents Chemother. 51(4), 1398–1406 (2007).
  Medline CASGoogle Scholar
• 55 Jiang Z, Kullberg BJ, van der Lee H et al. Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides. Chem. Biol. Drug Des. 72(6), 483–495 (2008).
  Medline CASGoogle Scholar
• 56 Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3(3), 238–250 (2005).
  Medline CASGoogle Scholar
• 57 Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415, 389–395 (2002).
  Medline CASGoogle Scholar
• 58 Abdolhosseini M, Nandula SR, Song J, Hirt H, Gorr SU. Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity. Peptides 35(2), 231–238 (2012).
  Medline CASGoogle Scholar
• 59 Gopal R, Park SC, Ha KJ et al. Effect of leucine and lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide. J. Pept. Sci. 15(9), 589–594 (2009). •• The effects of Leu and Lys substitution on functional properties of peptides, consisting of cationicity, antimicrobial activity and hemolytic activity is described in this report.
  Medline CASGoogle Scholar
• 60 Yang ST, Shin SY, Lee CW, Kim YC, Hahm KS, Kim JI. Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure. FEBS Lett. 540, 229–233 (2003).
  Medline CASGoogle Scholar
• 61 Wu Z, Cui Q, Yethiraj A. Why do arginine and lysine organize lipids differently? Insights from coarse-grained and atomistic simulations. J. Phys. Chem. B 117(40), 12145–12156 (2013).
  Medline CASGoogle Scholar
• 62 Conlon JM, Abdel-Wahab YH, Flatt PR et al. A glycine-leucine-rich peptide structurally related to the plasticins from skin secretions of the frog Leptodactylus laticeps (leptodactylidae). Peptides 30(5), 888–892 (2009).
  Medline CASGoogle Scholar
• 63 Lorenzini DM, Silva PI Jr, Fogaca AC, Bulet P, Daffre S. Acanthoscurrin: a novel glycine-rich antimicrobial peptide constitutively expressed in the hemocytes of the spider Acanthoscurria gomesiana. Dev. Comp. Immunol. 27, 781–791 (2003).
  Medline CASGoogle Scholar
• 64 Sousa JC, Berto RF, Gois EA et al. Leptoglycin: a new glycine/leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (leptodactylidae). Toxicon 54(1), 23–32 (2009).
  Medline CASGoogle Scholar
• 65 Ilic N, Novkovic M, Guida F et al. Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences. Biochim. Biophys. Acta 1828(3), 1004–1012 (2013).
  Medline CASGoogle Scholar
• 66 Pace CN, Scholtz JM. A helix propensity scale based on experimental studies of peptides and proteins. Biophys. J. 75, 422–427 (1998).
  Medline CASGoogle Scholar
• 67 Tsai CS. Biomacromolecules: Introduction to Structure, Function and Informatics. John Wiley & Sons, Inc., NJ, USA (2007).
  Google Scholar
• 68 Ponnuswamy PK, Prabhakaran M, Manavalan P. Hydrophobic packing and spatial arrangement of amino acid residues in globular proteins. Biochim. Biophys. Acta 623(2), 301–316 (1980).
  Medline CASGoogle Scholar
• 69 Roseman MA. Hydrophilicity of polar amino acid side-chains is markedly reduced by flanking peptide bonds. J. Mol. Biol. 200(3), 513–522 (1988).
  Medline CASGoogle Scholar
• 70 Wolfenden R, Andersson L, Cullis PM, Southgate CC. Affinities of amino acid side chains for solvent water. Biochemistry 20(4), 849–855 (1981).
  Medline CASGoogle Scholar
• 71 Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105–132 (1982).
  Medline CASGoogle Scholar
• 72 Janin J. Surface and inside volumes in globular proteins. Nature 277(5696), 491–492 (1979).
  Medline CASGoogle Scholar
• 73 Szymanowski J. The new method of hydrophobicity index calculation. In: Emulsions. Müller FH, Weiss A (Eds). Steinkopff, Heidelberg, Germany, 96–98 (1978).
  Google Scholar
• 74 Naderi-Manesh H, Sadeghi M, Arab S, Moosavi Movahedi AA. Prediction of protein surface accessibility with information theory. Proteins 42(4), 452–459 (2001).
  Medline CASGoogle Scholar
• 75 Dathe M, Wieprecht T, Nikolenko H et al. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 403, 208–212 (1997). •• Reports the influence of hydrophobicity on antibacterial and hemolytic activity of peptides.
  Medline CASGoogle Scholar
• 76 Lee J, Lee DG. Influence of the hydrophobic amino acids in the N- and C-terminal regions of pleurocidin on antifungal activity. J. Microbiol. Biotechnol. 20(8), 1192–1195 (2010).
  Medline CASGoogle Scholar
• 77 Polyansky AA, Vassilevski AA, Volynsky PE et al. N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. FEBS Lett. 583(14), 2425–2428 (2009). •• Describes the importance of the α-helix region on hemolytic and other cytotoxic activities of antimicrobial peptides.
  Medline CASGoogle Scholar
• 78 Chen Y, Mant CT, Farmer SW, Hancock REW, Vasil ML, Hodges RS. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 180(13), 12316–12329 (2005).
  Google Scholar
• 79 Yin LM, Edwards MA, Li J, Yip CM, Deber CM. Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide–membrane interactions. J. Biol. Chem. 287(10), 7738–7745 (2012).
  Medline CASGoogle Scholar
• 80 Jiang Z, Vasil AI, Gera L, Vasil ML, Hodges RS. Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, ‘specificity determinants’, total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Chem. Biol. Drug Des. 77(4), 225–240 (2011).
  MedlineGoogle Scholar
• 81 Huang YB, Wang XF, Wang HY, Liu Y, Chen Y. Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Mol. Cancer Ther. 10(3), 416–426 (2011).
  Medline CASGoogle Scholar
• 82 Monné M, Nilsson I, Elofsson A, von Heijne G. Turns in transmembrane helices: determination of the minimal length of a “helical hairpin” and derivation of a fine-grained turn propensity scale. J. Mol. Biol. 293(4), 807–814 (1999).
  Medline CASGoogle Scholar
• 83 Aurora R, Rose GD. Helix capping. Protein Sci. 7(1), 21–38 (1998).
  Medline CASGoogle Scholar
• 84 Hisamatsu K, Tsuda N, Goda S, Hatakeyama T. Characterization of the α-helix region in domain 3 of the haemolytic lectin CEL-III: implications for self-oligomerization and haemolytic processes. J. Biochem. 143(1), 79–86 (2008).
  Medline CASGoogle Scholar
• 85 Hatakeyama T, Kohzaki H, Nagatomo H, Yamasaki N. Purification and characterization of four Ca(2⁺)^- dependent lectins from the marine invertebrate, Cucumaria echinata. J. Biochem. 116, 209–214 (1994).
  Medline CASGoogle Scholar
• 86 Oda T, Tsuru M, Hatakeyama T, Nagatomo H, Muramatsu T, Yamasaki N. Temperature- and pH-dependent cytotoxic effect of the hemolytic lectin CEL-III from the marine invertebrate Cucumarai echinata on various cell lines. J. Biochem. 121, 560–567 (1997).
  Medline CASGoogle Scholar
• 87 Kouzuma Y, Suzuki Y, Nakano M et al. Characterization of functional domains of the hemolytic lectin CEL-III from the marine invertebrate Cucumaria echinata. J. Biochem. 134, 395–402 (2003).
  Medline CASGoogle Scholar
• 88 Palau J, Argos P, Puigdomenech P. Protein secondary structure. Studies on the limits of prediction accuracy. Int. J. Pept. Protein Res. 19(4), 394–401 (1982).
  Medline CASGoogle Scholar
• 89 Qian N, Sejnowski TJ. Predicting the secondary structure of globular proteins using neural network models. J. Mol. Biol. 202, 865–884 (1988).
  Medline CASGoogle Scholar
• 90 Nagano K. Logical analysis of the mechanism of protein folding I. Predictions of helices, loops and beta-structures from primary structure. J. Mol. Biol. 75, 401–420 (1973).
  Medline CASGoogle Scholar
• 91 Powers JP, Hancock RE. The relationship between peptide structure and antibacterial activity. Peptides 24(11), 1681–1691 (2003).
  Medline CASGoogle Scholar
• 92 Castano S, Desbat B, Dufourcq J. Ideally amphipathic β-sheeted peptides at interfaces: structure, orientation, affinities for lipids and hemolytic activity of (KL)mK peptides. Biochim. Biophys. Acta 1463, 65–80 (2000).
  Medline CASGoogle Scholar
• 93 Silva PI Jr, Daffre S, Bulet P. Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J. Biol. Chem. 275(43), 33464–33470 (2000).
  Medline CASGoogle Scholar
• 94 Wood SJ, Park YA, Kanneganti NP et al. Modified cysteine-deleted tachyplesin (CDT) analogs as linear antimicrobial peptides: influence of chain length, positive charge, and hydrophobicity on antimicrobial and hemolytic activity. Int. J. Pept. Res. Ther. 20, 519–530 (2014).
  CASGoogle Scholar
• 95 Nakamura T, Furunaka H, Miyata T, Tokunaga F, Muta T, Iwanaga S. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus), isolation and chemical structure. J. Biochem. 263(32), 16709–16713 (1988).
  CASGoogle Scholar
• 96 Ehret-Sabatier L, Loew D, Goyffon M et al. Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood. J. Biol. Chem. 271(47), 29537–29544 (1996).
  Medline CASGoogle Scholar
• 97 Katsu T, Nakao S, Iwanaga S. Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes. Biol. Pharm. Bull. 16(2), 178–181 (1993).
  Medline CASGoogle Scholar
• 98 Rao AG. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. Arch. Biochem. Biophys. 361(1), 127–134 (1999).
  Medline CASGoogle Scholar
• 99 Ramamoorthy A, Thennarasu S, Tan A et al. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and LPS selective binding. J. Biochem. 45(20), 6529–6540 (2006). •• Describes the role of Cys residues on hemolytic activity of peptides.
  CASGoogle Scholar
• 100 Wiradharma N, Khan M, Yong LK et al. The effect of thiol functional group incorporation into cationic helical peptides on antimicrobial activities and spectra. Biomaterials 32(34), 9100–9108 (2011).
  Medline CASGoogle Scholar